Topic
NeuWave
Podcasts
Vascular & IR # 548May 30, 2025Winding Down Neuwave: Impact on Interventional Radiology
It’s official — NeuWave is exiting the market. In this episode, Dr. Christopher Beck hosts a conversation with Dr. Josh Kuban, an interventional radiologist at MD Anderson Cancer Center, to discuss the impact that NeuWave's microwave tumor ablation technology has had on the field of interventional oncology and the recent announcement of its discontinuation, scheduled for March 2026.
Industry # 91May 30, 2025Winding Down Neuwave: Impact on Interventional Radiology
It’s official — NeuWave is exiting the market. In this episode, Dr. Christopher Beck hosts a conversation with Dr. Josh Kuban, an interventional radiologist at MD Anderson Cancer Center, to discuss the impact that NeuWave's microwave tumor ablation technology has had on the field of interventional oncology and the recent announcement of its discontinuation, scheduled for March 2026.
Urology # 228Apr 23, 2025Multidisciplinary Approaches to Renal Cancer Care
This week we bring together urologists and radiologists to work towards a shared goal of innovating on kidney cancer care. Dr. Jason Abel, Professor of Urology and Radiology at the University of Wisconsin, and Dr. Louis Hinshaw, Section Chief of Abdominal Imaging Intervention at the University of Wisconsin, join our host Dr. Ruchika Talwar for a multidisciplinary conversation regarding the treatment of renal tumors.
- Vascular & IR # 378Oct 25, 2023
Setting the Benchmark: Ablation Confirmation Software for Tumors
In this episode, Dr. Constantinos (Costi) Sofocleous, Dr. Bruno Odisio, and Dr. William Rilling discuss the history of percutaneous liver tumor ablation, takeaways from past and present clinical studies, and the contemporary role of ablation margin confirmation software for optimizing treatment outcomes.
- Vascular & IR # 257Oct 31, 2022
Microwave Ablation for Liver Lesions
In this episode, Dr. Chris Beck interviews Interventional Radiologist Dr. Josh Kuban about his liver tumor ablation practice at MD Anderson Cancer Center, including how it's evolved over time with newer technologies. They also discuss patient workup for liver tumors, treatment with microwave ablation, and post-procedure follow up. Dr. Kuban shares why he uses microwave ablation technology, and the advantages of ablation confirmation software for these procedures.
- Industry # 25Apr 29, 2022
Next Level Stuff, the Exit: Part III of the Neuwave Story
To close our BackTable Innovation series on NeuWave, we invited Laura King and Dr. Fred Lee to speak about growing their medical device company through various stages, from Series A funding to acquisition by Johnson & Johnson.
- Industry # 24Apr 28, 2022
Trials and Tribulations: Part II of the Neuwave Story
We talk with electrical engineering professor Dr. Dan van der Weide and interventional radiologist Dr. Fred Lee about the lessons they learned in the early stages of founding their microwave ablation device company, including challenges with early teams and equity.
- Industry # 23Apr 26, 2022
Approach the Problem with Vision: Part I of the Neuwave Story
This is the first episode of a 3-part series on the origin, rise, and acquisition of NeuWave Medical, Inc., a medical device company focused on microwave ablation. In this first installment, we interview co-founder Dr. Fred Lee about his vision for starting the company. Dr. Lee takes us through his family history that shaped his identity as an innovator. His father was involved in the development of cryoablation as a treatment for prostate cancer, which inspired him to find applications for ablation in other types of cancer.